AAAAAA

   
Results: 1-19 |
Results: 19
BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS/
Authors: KAPIL RP EMM TA MOUSA SA PADOVANI PK QUON CY LAM GN
Citation: Rp. Kapil et al., BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS/, Thrombosis research, 86(3), 1997, pp. 221-232
PHARMACOKINETICS AND METABOLISM OF EXP921, A NOVEL COGNITIVE ENHANCER, IN RATS
Authors: WONG YN QUON CY HOLM KA BURCHAM DL FREY NL HUANG SM LAM GN
Citation: Yn. Wong et al., PHARMACOKINETICS AND METABOLISM OF EXP921, A NOVEL COGNITIVE ENHANCER, IN RATS, Drug metabolism and disposition, 24(2), 1996, pp. 172-179
BINDING OF FOSPHENYTOIN, PHOSPHATE ESTER PRO DRUG OF PHENYTOIN, TO HUMAN SERUM-PROTEINS AND COMPETITIVE-BINDING WITH CARBAMAZEPINE, DIAZEPAM, PHENOBARBITAL, PHENYLBUTAZONE, PHENYTOIN, VALPROIC ACID OR WARFARIN
Authors: LAI CM MOORE P QUON CY
Citation: Cm. Lai et al., BINDING OF FOSPHENYTOIN, PHOSPHATE ESTER PRO DRUG OF PHENYTOIN, TO HUMAN SERUM-PROTEINS AND COMPETITIVE-BINDING WITH CARBAMAZEPINE, DIAZEPAM, PHENOBARBITAL, PHENYLBUTAZONE, PHENYTOIN, VALPROIC ACID OR WARFARIN, Research communications in molecular pathology and pharmacology, 88(1), 1995, pp. 51-62
POLYMORPHIC METABOLISM OF FLESTOLOL AND OTHER ESTER-CONTAINING COMPOUNDS BY A CARBOXYLESTERASE IN NEW-ZEALAND WHITE-RABBIT BLOOD AND CORNEA
Authors: STAMPFLI HF QUON CY
Citation: Hf. Stampfli et Cy. Quon, POLYMORPHIC METABOLISM OF FLESTOLOL AND OTHER ESTER-CONTAINING COMPOUNDS BY A CARBOXYLESTERASE IN NEW-ZEALAND WHITE-RABBIT BLOOD AND CORNEA, Research communications in molecular pathology and pharmacology, 88(1), 1995, pp. 87-97
THE EFFECT OF ABSORPTION ENHANCERS ON THE ORAL ABSORPTION OF THE GP IIB IIIA RECEPTOR ANTAGONIST, DMP-728, IN RATS AND DOGS/
Authors: BURCHAM DL AUNGST BA HUSSAIN M GORKO MA QUON CY HUANG SM
Citation: Dl. Burcham et al., THE EFFECT OF ABSORPTION ENHANCERS ON THE ORAL ABSORPTION OF THE GP IIB IIIA RECEPTOR ANTAGONIST, DMP-728, IN RATS AND DOGS/, Pharmaceutical research, 12(12), 1995, pp. 2065-2070
A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS (VOL 15, PG 535, 1994)
Authors: WONG YN BURCHAM DL SAXTON PL ERICKSONVIITANEN S GRUBB MF QUON CY HUANG SM
Citation: Yn. Wong et al., A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS (VOL 15, PG 535, 1994), Biopharmaceutics & drug disposition, 16(2), 1995, pp. 2-2
DETERMINATION OF DUP-128, AN ACAT INHIBITOR AND ITS SULFOXIDE AND SULFONE METABOLITES IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY
Authors: LAI CM BROGDON B QUON CY PIENIASZEK HJ
Citation: Cm. Lai et al., DETERMINATION OF DUP-128, AN ACAT INHIBITOR AND ITS SULFOXIDE AND SULFONE METABOLITES IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY, Journal of pharmaceutical and biomedical analysis, 12(9), 1994, pp. 1163-1172
PROTEIN-BINDING OF BREQUINAR IN THE PLASMA OF HEALTHY DONORS AND CANCER-PATIENTS AND ANALYSIS OF THE RELATIONSHIP BETWEEN PROTEIN-BINDING AND PHARMACOKINETICS IN CANCER-PATIENTS
Authors: KING SYP AGRA AM SHEN HSL CHI CL ADAMS DB CURRIE VE BERTINO JR PIENIASZEK HJ QUON CY
Citation: Syp. King et al., PROTEIN-BINDING OF BREQUINAR IN THE PLASMA OF HEALTHY DONORS AND CANCER-PATIENTS AND ANALYSIS OF THE RELATIONSHIP BETWEEN PROTEIN-BINDING AND PHARMACOKINETICS IN CANCER-PATIENTS, Cancer chemotherapy and pharmacology, 35(2), 1994, pp. 101-108
PHARMACOKINETICS OF THE INODILATOR XB513 IN MICE, RATS, GUINEA-PIGS, RABBITS, DOGS, AND MONKEYS
Authors: STAMPFLI HF PERSON CR HUANG SM QUON CY
Citation: Hf. Stampfli et al., PHARMACOKINETICS OF THE INODILATOR XB513 IN MICE, RATS, GUINEA-PIGS, RABBITS, DOGS, AND MONKEYS, Biopharmaceutics & drug disposition, 15(9), 1994, pp. 789-793
A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS
Authors: WONG YN BURCHAM DL SAXTON PL ERICKSONVIITANEN S GRUBB MF QUON CY HUANG SM
Citation: Yn. Wong et al., A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS, Biopharmaceutics & drug disposition, 15(7), 1994, pp. 535-544
THE EFFECT OF HEPATIC-DISEASE ON THE DISPOSITION OF MORICIZINE IN HUMANS
Authors: PIENIASZEK HJ DAVIDSON AF MCENTEGART CM QUON CY SAMPLINER RE MAYERSOHN M
Citation: Hj. Pieniaszek et al., THE EFFECT OF HEPATIC-DISEASE ON THE DISPOSITION OF MORICIZINE IN HUMANS, Biopharmaceutics & drug disposition, 15(3), 1994, pp. 243-252
THE PHARMACOKINETICS AND METABOLISM OF DUP 532, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN RATS AND DOGS
Authors: WONG YN HOLM KA BURCHAM DL HUANG SM QUON CY
Citation: Yn. Wong et al., THE PHARMACOKINETICS AND METABOLISM OF DUP 532, A NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN RATS AND DOGS, Biopharmaceutics & drug disposition, 15(1), 1994, pp. 53-63
PHARMACOKINETICS OF HIV PROTEASE INHIBITOR DMP-323 IN RATS AND DOGS
Authors: GRUBB MF WONG YN BURCHAM DL SAXTON PL QUON CY HUANG SM
Citation: Mf. Grubb et al., PHARMACOKINETICS OF HIV PROTEASE INHIBITOR DMP-323 IN RATS AND DOGS, Drug metabolism and disposition, 22(5), 1994, pp. 709-712
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN POTASSIUM (DUP 753 MK 954) IN THE DOG/
Authors: CHRIST DD WONG PC WONG YN HART SD QUON CY LAM GN
Citation: Dd. Christ et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN POTASSIUM (DUP 753 MK 954) IN THE DOG/, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1199-1205
PLASMA-PROTEIN BINDING OF HIGHLY BOUND DRUGS - IMPLICATIONS OF RADIOCHEMICAL IMPURITIES
Authors: JOSHI AS PIENIASZEK HJ QUON CY KING SYP
Citation: As. Joshi et al., PLASMA-PROTEIN BINDING OF HIGHLY BOUND DRUGS - IMPLICATIONS OF RADIOCHEMICAL IMPURITIES, Journal of pharmaceutical sciences, 83(8), 1994, pp. 1187-1188
METABOLISM AND DISPOSITION OF EXP631 - A NOVEL ANTIDEPRESSANT ANALGESIC
Authors: WONG YN BURCHAM DL HUANG SM QUON CY
Citation: Yn. Wong et al., METABOLISM AND DISPOSITION OF EXP631 - A NOVEL ANTIDEPRESSANT ANALGESIC, Biopharmaceutics & drug disposition, 14(6), 1993, pp. 519-531
BIOCHEMICAL-CHARACTERIZATION OF FLESTOLOL ESTERASE
Authors: QUON CY STAMPFLI HF
Citation: Cy. Quon et Hf. Stampfli, BIOCHEMICAL-CHARACTERIZATION OF FLESTOLOL ESTERASE, Research communications in chemical pathology and pharmacology, 81(3), 1993, pp. 309-322
MONO(AMINOMETHYL)PHENYLACETIC AND BIS(AMINOMETHYL)PHENYLACETIC ACID-ESTERS AS SHORT-ACTING ANTIARRHYTHMIC AGENTS .2.
Authors: CHORVAT RJ BLACK LA RANADE VV BARCELONYANG C STOUT DM BROWN BS STAMPFLI HF QUON CY
Citation: Rj. Chorvat et al., MONO(AMINOMETHYL)PHENYLACETIC AND BIS(AMINOMETHYL)PHENYLACETIC ACID-ESTERS AS SHORT-ACTING ANTIARRHYTHMIC AGENTS .2., Journal of medicinal chemistry, 36(17), 1993, pp. 2494-2498
EFFECTS OF MULTIPLE DOSES OF MORICIZINE HYDROCHLORIDE ON ITS PHARMACOKINETICS AND HEPATIC-MICROSOMAL ENZYMES IN RATS
Authors: KING SYP POWEL RJ WONG YN DAVIDSON AF VINCENT DR QUON CY PIENIASZEK HJ
Citation: Syp. King et al., EFFECTS OF MULTIPLE DOSES OF MORICIZINE HYDROCHLORIDE ON ITS PHARMACOKINETICS AND HEPATIC-MICROSOMAL ENZYMES IN RATS, Research communications in chemical pathology and pharmacology, 75(3), 1992, pp. 259-274
Risultati: 1-19 |